BAIYING HOLDING (08525): Guan Lexin appointed as joint company secretary and authorized representative.
Hundreds of Holdings (08525) announced that there have been changes in the joint company secretary and authorized representative effective from December 24, 2025: Ms. Wu Jiawen has resigned as joint company secretary and authorized representative due to work arrangements, while Ms. Guan Lexin has been appointed as joint company secretary and authorized representative. Ms. Yang Lexing has resigned as joint company secretary for personal reasons, and Ms. Shi Jingyi has been appointed as the joint company secretary. The Stock Exchange has approved the appointment of Ms. Shi Jingyi as joint company secretary, exempting the company from strict compliance with GEM Listing Rules 5.14 and 11.07(2) for a period of three years from the date of appointment.
BAIYING HOLDING (08525) announced that there have been changes to the joint company secretary and authorized representatives of the company effective from December 24, 2025: Ms. Wu Jiawen has resigned as joint company secretary and authorized representative due to work arrangements, and Ms. Guan Lexin has been appointed as the new joint company secretary and authorized representative; Ms. Yang Lexing has resigned as joint company secretary for personal reasons, and Ms. Shi Jingyi has been appointed as the new joint company secretary. The Stock Exchange has approved the appointment of Ms. Shi Jingyi as joint company secretary and granted the company a waiver from strict compliance with GEM Listing Rules 5.14 and 11.07(2) for a period of three years from the date of her appointment.
Related Articles
SHOUHUI GROUP (02621) spent HK$67,600 to repurchase 19,600 shares on December 29th.
RECBIO-B(02179): The new drug application for the adjuvanted recombinant herpes zoster vaccine REC610 has been accepted by the National Medical Products Administration.
China Unicom (02671) launched a public offering in Hong Kong with a price cap and received 146.25 times oversubscription.
SHOUHUI GROUP (02621) spent HK$67,600 to repurchase 19,600 shares on December 29th.
RECBIO-B(02179): The new drug application for the adjuvanted recombinant herpes zoster vaccine REC610 has been accepted by the National Medical Products Administration.
China Unicom (02671) launched a public offering in Hong Kong with a price cap and received 146.25 times oversubscription.
